Semglee - Insulin Glargine Interchangeable with Lantus

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2021年 / 63卷 / 1634期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：159 / 160
页数：2
相关论文
共 50 条
  • [1] Rezvoglar - Another Insulin Glargine Product Interchangeable with Lantus
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2023, 65 (1673): : 56 - 56
  • [2] Insulin glargine (Lantus®)
    Owens, DR
    Griffiths, S
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2002, 56 (06) : 460 - 466
  • [3] Semglee - A New Insulin Glargine for Diabetes
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2021, 63 (1616):
  • [4] Insulin Glargine (Lantus) and Cancer Risk
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2009, 51 (1319): : 67 - 68
  • [5] No evidence for accumulation of insulin glargine (LANTUS)
    Biermann, E
    DIABETIC MEDICINE, 2003, 20 (04) : 333 - 334
  • [6] Kinetics and metabolite profile of insulin glargine (Lantus®)
    Kuerzel, GU
    Sandow, J
    Seipke, G
    Lang, AM
    Mass, J
    Skrzipczyk, HJ
    DIABETOLOGIA, 2001, 44 : A208 - A208
  • [7] No evidence for accumulation of insulin glargine (LANTUS) - Reply
    Heise, T
    DIABETIC MEDICINE, 2003, 20 (04) : 334 - 335
  • [8] Insulin glargine (Lantus), a new long-acting insulin
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2001, 43 (1110): : 65 - 66
  • [9] The First Interchangeable Biosimilar Insulin: Insulin Glargine-yfgn
    Matli, Mark C.
    Wilson, Andrea B.
    Rappsilber, Leah M.
    Sheffield, Farron P.
    Farlow, Miranda L.
    Johnson, Jeremy L.
    JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2023, 17 (02): : 490 - 494
  • [10] Evaluation of the carcinogenic potential of insulin glargine (LANTUS) in rats and mice
    Stammberger, I
    Bube, A
    Durchfeld-Meyer, B
    Donaubauer, H
    Troschau, G
    INTERNATIONAL JOURNAL OF TOXICOLOGY, 2002, 21 (03) : 171 - 179
12345